TY - JOUR
T1 - Reactive Oxygen-Forming Nox5 Links Vascular Smooth Muscle Cell Phenotypic Switching and Extracellular Vesicle-Mediated Vascular Calcification
AU - Furmanik, Malgorzata
AU - Chatrou, Martijn
AU - van Gorp, Rick
AU - Akbulut, Asim
AU - Willems, Brecht
AU - Schmidt, Harald
AU - van Eys, Guillaume
AU - Bochaton-Piallat, Marie Luce
AU - Proudfoot, Diane
AU - Biessen, Erik
AU - Hedin, Ulf
AU - Perisic, Ljubica
AU - Mees, Barend
AU - Shanahan, Catherine
AU - Reutelingsperger, Chris
AU - Schurgers, Leon
PY - 2020/9/11
Y1 - 2020/9/11
N2 - Rationale: Vascular calcification, the formation of calcium phosphate crystals in the vessel wall, is mediated by vascular smooth muscle cells (VSMCs). However, the underlying molecular mechanisms remain elusive, precluding mechanism-based therapies. Objective: Phenotypic switching denotes a loss of contractile proteins and an increase in migration and proliferation, whereby VSMCs are termed synthetic. We examined how VSMC phenotypic switching influences vascular calcification and the possible role of the uniquely calcium-dependent reactive oxygen species (ROS)-forming Nox5 (NADPH oxidase 5). Methods and Results: In vitro cultures of synthetic VSMCs showed decreased expression of contractile markers CNN-1 (calponin 1), -SMA (-smooth muscle actin), and SM22- (smooth muscle protein 22) and an increase in synthetic marker S100A4 (S100 calcium binding protein A4) compared with contractile VSMCs. This was associated with increased calcification of synthetic cells in response to high extracellular Ca
2+. Phenotypic switching was accompanied by increased levels of ROS and Ca
2+-dependent Nox5 in synthetic VSMCs. Nox5 itself regulated VSMC phenotype as siRNA knockdown of Nox5 increased contractile marker expression and decreased calcification, while overexpression of Nox5 decreased contractile marker expression. ROS production in synthetic VSMCs was cytosolic Ca
2+-dependent, in line with it being mediated by Nox5. Treatment of VSMCs with Ca
2+loaded extracellular vesicles (EVs) lead to an increase in cytosolic Ca
2+. Inhibiting EV endocytosis with dynasore blocked the increase in cytosolic Ca
2+and VSMC calcification. Increased ROS production resulted in increased EV release and decreased phagocytosis by VSMCs. Conclusions: We show here that contractile VSMCs are resistant to calcification and identify Nox5 as a key regulator of VSMC phenotypic switching. Additionally, we describe a new mechanism of Ca
2+uptake via EVs and show that Ca
2+induces ROS production in VSMCs via Nox5. ROS production is required for release of EVs, which promote calcification. Identifying molecular pathways that control Nox5 and VSMC-derived EVs provides potential targets to modulate vascular remodeling and calcification in the context of mineral imbalance.
AB - Rationale: Vascular calcification, the formation of calcium phosphate crystals in the vessel wall, is mediated by vascular smooth muscle cells (VSMCs). However, the underlying molecular mechanisms remain elusive, precluding mechanism-based therapies. Objective: Phenotypic switching denotes a loss of contractile proteins and an increase in migration and proliferation, whereby VSMCs are termed synthetic. We examined how VSMC phenotypic switching influences vascular calcification and the possible role of the uniquely calcium-dependent reactive oxygen species (ROS)-forming Nox5 (NADPH oxidase 5). Methods and Results: In vitro cultures of synthetic VSMCs showed decreased expression of contractile markers CNN-1 (calponin 1), -SMA (-smooth muscle actin), and SM22- (smooth muscle protein 22) and an increase in synthetic marker S100A4 (S100 calcium binding protein A4) compared with contractile VSMCs. This was associated with increased calcification of synthetic cells in response to high extracellular Ca
2+. Phenotypic switching was accompanied by increased levels of ROS and Ca
2+-dependent Nox5 in synthetic VSMCs. Nox5 itself regulated VSMC phenotype as siRNA knockdown of Nox5 increased contractile marker expression and decreased calcification, while overexpression of Nox5 decreased contractile marker expression. ROS production in synthetic VSMCs was cytosolic Ca
2+-dependent, in line with it being mediated by Nox5. Treatment of VSMCs with Ca
2+loaded extracellular vesicles (EVs) lead to an increase in cytosolic Ca
2+. Inhibiting EV endocytosis with dynasore blocked the increase in cytosolic Ca
2+and VSMC calcification. Increased ROS production resulted in increased EV release and decreased phagocytosis by VSMCs. Conclusions: We show here that contractile VSMCs are resistant to calcification and identify Nox5 as a key regulator of VSMC phenotypic switching. Additionally, we describe a new mechanism of Ca
2+uptake via EVs and show that Ca
2+induces ROS production in VSMCs via Nox5. ROS production is required for release of EVs, which promote calcification. Identifying molecular pathways that control Nox5 and VSMC-derived EVs provides potential targets to modulate vascular remodeling and calcification in the context of mineral imbalance.
KW - calcium
KW - extracellular vesicles
KW - NADPH oxidase 5
KW - phenotype
KW - vascular calcification
UR - http://www.scopus.com/inward/record.url?scp=85088392061&partnerID=8YFLogxK
U2 - 10.1161/CIRCRESAHA.119.316159
DO - 10.1161/CIRCRESAHA.119.316159
M3 - Article
C2 - 32564697
AN - SCOPUS:85088392061
SN - 0009-7330
VL - 127
SP - 911
EP - 927
JO - Circulation Research
JF - Circulation Research
IS - 7
ER -